Basic Information
Basic information for FTX-264-19aa
Peptide Name FTX-264-19aa
Genome Position chrX:74203079-74203135[-]
Species Human
Peptide Sequence MTSEAEEESLSLLSLSHRD
Peptide Length 19
Unique No (FTX-202-19aa,FTX-210-19aa-1,FTX-218-19aa,FTX-223-19aa,FTX-224-19aa,FTX-228-19aa,FTX-229-19aa,FTX-231-19aa,FTX-233-19aa,FTX-236-19aa,FTX-238-19aa,FTX-241-19aa,FTX-245-19aa,FTX-257-19aa,FTX-261-19aa,FTX-265-19aa,FTX-266-19aa,FTX-268-19aa)
Grand Average of Hydropathicity -0.5789
Relative Molecular Mass 2458.57
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000665069;FTX-264
Transcript Length 1958
Coding Ability 0.6001
DNA Sequence Corresponding to Peptide ATGACATCTGAAGCTGAAGAGGAGTCCCTCTCATTGTTGTCATTGTCCCACCGGGAC
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :